|
VEEV
|
Healthcare |
Truist |
Downgrade
|
Buy
→
Hold
|
—
|
$27.3B
|
$175.78
|
-0.7%
|
-1.8%
|
+0.5%
|
+2.0%
|
-1.8%
|
+0.1%
|
|
SYF
|
Financial Services |
Keefe, Bruyette & Woods |
Downgrade
|
Market Outperform
→
Market Perform
|
—
|
$24.8B
|
$29.16
|
-0.7%
|
-2.3%
|
-0.1%
|
+5.1%
|
-3.2%
|
-3.2%
|
|
DG
|
Consumer Defensive |
Gordon Haskett |
Downgrade
|
Accumulate
→
Hold
|
—
|
$22.9B
|
$212.09
|
-0.3%
|
-1.5%
|
+0.7%
|
-0.1%
|
-1.7%
|
-1.7%
|
|
DOCN
|
Technology |
Oppenheimer |
Downgrade
|
Outperform
→
Perform
|
—
|
$15.8B
|
$35.05
|
-3.6%
|
-2.8%
|
+1.8%
|
+2.1%
|
-2.7%
|
+2.9%
|
|
BFH
|
Financial Services |
Keefe, Bruyette & Woods |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$4.0B
|
$31.46
|
-4.2%
|
-6.6%
|
-0.9%
|
+3.8%
|
-2.6%
|
-5.1%
|
|
RNG
|
Technology |
Oppenheimer |
Downgrade
|
Outperform
→
Perform
|
—
|
$3.7B
|
$31.97
|
-3.0%
|
-5.9%
|
-6.1%
|
+4.5%
|
-6.1%
|
-1.6%
|
|
TEX
|
Industrials |
BofA Securities |
Downgrade
|
Buy
→
Neutral
|
—
|
$3.7B
|
$49.68
|
-2.6%
|
-8.8%
|
+3.8%
|
+4.8%
|
-3.7%
|
-1.8%
|
|
BBWI
|
Consumer Cyclical |
Argus |
Downgrade
|
Buy
→
Hold
|
—
|
$3.6B
|
$35.25
|
-3.0%
|
-2.3%
|
+1.1%
|
+2.7%
|
-2.3%
|
-1.7%
|
|
BRZE
|
Technology |
UBS |
Downgrade
|
Buy
→
Neutral
|
—
|
$2.5B
|
$33.15
|
-7.3%
|
-5.8%
|
-1.9%
|
+5.1%
|
-4.5%
|
+1.2%
|
|
ONDS
|
Technology |
Oppenheimer |
Downgrade
|
Outperform
→
Perform
|
—
|
$2.0B
|
$1.46
|
-2.1%
|
-11.0%
|
-10.8%
|
+6.9%
|
-4.8%
|
-6.8%
|
|
NVCR
|
Healthcare |
JP Morgan |
Downgrade
|
Neutral
→
Underweight
|
—
|
$1.9B
|
$64.43
|
-8.4%
|
-11.4%
|
+2.4%
|
+0.5%
|
-3.9%
|
+0.7%
|
|
EBS
|
Healthcare |
JP Morgan |
Downgrade
|
Neutral
→
Underweight
|
—
|
$457M
|
$9.65
|
-8.8%
|
-15.9%
|
-0.6%
|
+1.2%
|
-4.7%
|
+0.9%
|
|
HNST
|
Consumer Cyclical |
Telsey Advisory Group |
Downgrade
|
Outperform
→
Perform
|
—
|
$358M
|
$1.86
|
-1.6%
|
-6.5%
|
-1.7%
|
+2.9%
|
-7.4%
|
+1.8%
|
|
HNST
|
Consumer Cyclical |
Telsey Advisory Group |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$358M
|
$1.86
|
-1.6%
|
-6.5%
|
-1.7%
|
+2.9%
|
-7.4%
|
+1.8%
|
|
MGNX
|
Healthcare |
Guggenheim |
Downgrade
|
Buy
→
Neutral
|
—
|
$285M
|
$6.99
|
-9.2%
|
-4.9%
|
+0.6%
|
+6.4%
|
-5.8%
|
+3.6%
|
|
REE
|
Consumer Cyclical |
Cantor Fitzgerald |
Downgrade
|
Overweight
→
Neutral
|
—
|
$11M
|
$11.40
|
+2.6%
|
-6.1%
|
-13.2%
|
-3.2%
|
+3.0%
|
-4.5%
|